Vanderbilt Institute for Infection Immunology and Inflammation (VI4)

Jeff Balser, MD, PhD, left, Jennifer Pietenpol, PhD, and Eric Skaar, PhD, pose for a photo during a recent tour of new space for the Vanderbilt Institute for Infection, Immunology and Inflammation.

New space bolsters infectious disease and immunology discovery

The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.

C. diff captures blood cell cofactor to build defensive shield

Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics.

The adaptable anthrax bacterium

Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Richard Locksley, MD, right, spoke about his allergic diseases research during his recent Flexner Discovery Lecture. Here, he poses for a photo with VUMC’s Eric Skaar, PhD, MPH.

Locksley’s Discovery Lecture

Richard Locksley, MD, spoke about his allergic diseases research during his recent Flexner Discovery Lecture. Here, he poses for a photo with VUMC’s Eric Skaar, PhD, MPH.

Zinc uptake by a deadly pathogen

The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses.

Wexler receives Helen Hay Whitney Foundation Fellowship

Aaron Wexler, PhD, a research fellow in the Department of Pathology, Microbiology and Immunology, has received a Helen Hay Whitney Foundation Fellowship.

1 2 3 4 5